USFDA issues EIR for Granules India’s Bonthapally facility in Hyderabad
US Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR) for Granules India’s Bonthapally facility located at Hyderabad, Telangana, India. This facility was…